- Home
- What We Do
- Investment Banking
- Transactions
Transactions
Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 80 transactions and raising C$6.1 billion on behalf of our clients in Q1/231.2.
Pending Completion
Eleusis Therapeutics
Exclusive Financial Advisor (Sell side)
HEALTHCARE
M&A ADVISORY
US
UK
View transaction detail
November 2022
Nox Health
Exclusive Financial Advisor (Sell side)
HEALTHCARE
FINANCIAL SPONSORS
M&A ADVISORY
US
View transaction detail
US$117.5m
November 2022
Privia Health
Passive Bookrunner (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
US$400m
November 2022
Natera
Co-Manager (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
US$230m
September 2022
Akero Therapeutics, Inc.
Lead Manager (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
US$10m
August 2022
Aytu BioPharma
Joint Bookrunner (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
US$130m
August 2022
TransMedics Group, Inc.
Lead Manager (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
August 2022
Sound Healthcare Communications
Financial Advisor to Sound Healthcare Communications on its Sale to Medical Knowledge Group
TECHNOLOGY
HEALTHCARE
M&A ADVISORY
US
View transaction detail
August 2022
Biorez, Inc.
Financial Advisor (Sell side)
HEALTHCARE
M&A ADVISORY
US
View transaction detail
July 2022
Amplifire
Canaccord Genuity Advises Amplifire, a Portfolio Company of Leeds Equity Partners, on its Significant Strategic Investment from Polaris Growth Fund
HEALTHCARE
TECHNOLOGY
FINANCIAL SPONSORS
M&A ADVISORY
US
View transaction detail
July 2022
Stratasan
Exclusive Financial Advisor (Sell side)
HEALTHCARE
M&A ADVISORY
FINANCIAL SPONSORS
US
View transaction detail
US$65m
June 2022
Oncolytics Biotech
Agent (ATM Offering)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
- Company information as of June 30, 2022
- Transactions valued above C$1.5 million
* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description
How can we help?
If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.